Abstract:Amyotrophic lateral sclerosis (ALS) is intensively associated with insoluble aggregates formed by transactivation response element DNA-binding protein 43 (TDP-43) in the cytoplasm of neuron cells. A recent experimental study reported that two ALS-linked familial variants, A315E and A315pT (pT, phosphorylated threonine), can induce irreversible aggregation of the TDP-43 312NFGAFS317 segment (TDP-43312-317). However, the underlying molecular mechanism remains largely elusive. Here, we investigated the early aggregation process of the wild type (WT) 312NFGAFS317 segment and its A315E and A315pT variants by performing multiple microsecond all-atom molecular dynamics simulations. Our simulations show that the two variants display lower fluidity than WT, consistent with their decreased labilities observed in previous denaturation assay experiments. Despite each of the two variants carrying one negative charge, unexpectedly, we find that both A315E mutation and A315pT phosphorylation enhance intermolecular interactions and result in the formation of more compact oligomers. Compared to WT, A315E oligomers possess low β-sheet content but a compact hydrophobic core, while A315pT oligomers have high β-sheet content and large β-sheets. Side chain hydrogen-bonding and hydrophobic interactions as well as N312-E315 salt bridges contribute most to the increased aggregation propensity of the A315E mutant. By contrast, main chain and side chain hydrogen-bonding interactions, side chain hydrophobic and aromatic interactions, are crucial to the enhanced aggregation capability of the A315pT variant. These results indicate that glutamate mutation and phosphorylation at position 315 induce the irreversible aggregation of TDP-43312-317 peptides through differential mechanisms, which remind us that we should be careful in the investigation of the phosphorylation effect on protein aggregation by using phosphomimetic substitutions. This study provides mechanistic insights into the A315E/A315pT-induced irreversible aggregation of TDP-43312-317, which may be helpful for the in-depth understanding of ALS-mutation/phosphorylation-associated liquid-to-solid phase transition of TDP-43 protein aggregates.

Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils

ALS-Linked A315T and A315E Mutations Enhance beta-Barrel Formation of the TDP-43307-319 Hexamer: A REST2 Simulation Study

ALS-associated A315E and A315pT Variants Exhibit Distinct Mechanisms in Inducing Irreversible Aggregation of TDP-43312-317 Peptides.

Dissecting the Effect of ALS Mutation G335D on the Early Aggregation of the TDP-43 Amyloidogenic Core Peptide: Helix-to-β-Sheet Transition and Conformational Shift.

ALS-Linked A315T and A315E Mutations Enhance ?-Barrel Formation of the TDP-43307-319 Hexamer: A REST2 Simulation Study

Influence of ALS-linked M337V Mutation on the Conformational Ensembles of TDP-43321-340 Peptide Monomer and Dimer

An ALS-associated Mutation Affecting TDP-43 Enhances Protein Aggregation, Fibril Formation and Neurotoxicity

Characterization of Β-Domains in C-terminal Fragments of TDP-43 by Scanning Tunneling Microscopy

An ALS-mutant TDP-43 Neurotoxic Peptide Adopts an Anti-Parallel Β-Structure and Induces TDP-43 Redistribution.

Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43 370-375 fragment

Solid-State NMR Reveals the Structural Transformation of the TDP-43 Amyloidogenic Region upon Fibrillation

Dissecting How ALS-associated D290V Mutation Enhances Pathogenic Aggregation of Hnrnpa2286–291 Peptides: Dynamics and Conformational Ensembles

Structure of pathological TDP-43 filaments from ALS with FTLD

Cryo-EM structures of four polymorphic TDP-43 amyloid cores

Insights into the Aggregation Mechanism of RRM Domains in TDP-43: A Molecular Dynamics Study

Atomistic Insights into the Stabilization of TDP-43 Protofibrils by ATP

Structural details of helix-mediated TDP-43 C-terminal domain multimerization

Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain

Phe-Gly motifs drive fibrillization of TDP-43’s prion-like domain condensates

Insights into the Aggregation Mechanism of RNA Recognition Motif Domains in TDP-43: a Theoretical Exploration

A TDP-43 acetylation-mimic mutation that disrupts RNA-binding drives FTLD-like neurodegeneration in a mouse model of sporadic TDP-43 proteinopathy